Distribution of cytogenetic risk groups
| SG group . | Observed (expected) count . | ||
|---|---|---|---|
| Favorable . | Intermediate . | Unfavorable . | |
| 1 | 1 (2.83) | 19 (15.84) | 14 (15.33) |
| 2 | 12 (4.17)* | 19 (23.30) | 19 (22.54) |
| 3 | 4 (3.42) | 25 (19.10)* | 12 (18.48)* |
| 4 | 2 (3.25) | 19 (18.17) | 18 (17.58) |
| 5 | 1 (2.67) | 8 (14.91)* | 23 (14.42)* |
| 6 | 2 (2.92) | 21 (16.31)* | 12 (15.78) |
| 7 | 0 (2.75)* | 12 (15.38) | 21 (14.88)* |
| SG group . | Observed (expected) count . | ||
|---|---|---|---|
| Favorable . | Intermediate . | Unfavorable . | |
| 1 | 1 (2.83) | 19 (15.84) | 14 (15.33) |
| 2 | 12 (4.17)* | 19 (23.30) | 19 (22.54) |
| 3 | 4 (3.42) | 25 (19.10)* | 12 (18.48)* |
| 4 | 2 (3.25) | 19 (18.17) | 18 (17.58) |
| 5 | 1 (2.67) | 8 (14.91)* | 23 (14.42)* |
| 6 | 2 (2.92) | 21 (16.31)* | 12 (15.78) |
| 7 | 0 (2.75)* | 12 (15.38) | 21 (14.88)* |
The 3 major cytogenetic risk groups are unevenly distributed across the seven protein signature groups. Each cell contains the observed (and expected under the null hypothesis) number of patients in each group.
Observations that differed most from the expected values (and thus contributed significantly to the χ2 test).